Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tachykinins and the cardiovascular system.

David A Walsh1, Daniel F McWilliams

  • 1Division of Academic Rheumatology, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham, NG5 1PB, UK. david.walsh@nottingham.ac.uk

Current Drug Targets
|August 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Shining a light on chronic pain": A qualitative study of stakeholder views towards chronic pain at work and the Pain-at-Work Toolkit.

PloS one·2026
Same author

Pain and neuropsychiatric symptoms in community-dwelling people living with dementia: a cross-sectional dyadic study.

BMC geriatrics·2026
Same author

The importance of central sensitization for clinical trials of disease modifying osteoarthritis drugs (DMOADs).

Osteoarthritis imaging·2026
Same author

Assessing central nervous system contributions to accelerate musculoskeletal pain diagnosis and treatment (AsCent): protocol for a mixed-method, prospective observational study.

BMJ open·2026
Same author

Prevalence of foot/ankle osteoarthritis and pain in retired male professional footballers compared with general population male controls: a cross-sectional study.

Rheumatology (Oxford, England)·2026
Same author

Patient and public involvement in musculoskeletal pain research: using mutual learning to improve research quality.

Therapeutic advances in musculoskeletal disease·2026

Tachykinins, vasoactive peptides, impact blood vessels and inflammation via neurokinin receptors. Understanding these effects offers potential therapeutic targets for various cardiovascular and inflammatory diseases.

Area of Science:

  • Cardiovascular Pharmacology
  • Vascular Biology
  • Neuroinflammation

Background:

  • The tachykinin family includes substance P, neurokinin A, neurokinin B, endokinins, and hemokinins.
  • These peptides exert cardiovascular effects primarily through neurokinin receptors.
  • Tachykinins are involved in plasma extravasation, neurogenic inflammation, and angiogenesis.

Purpose of the Study:

  • To review recent advances in understanding tachykinin effects on vasculature.
  • To summarize the therapeutic potential of targeting tachykinin-neurokinin receptor interactions.

Main Methods:

  • Literature review of studies on tachykinins and their cardiovascular effects.
  • Analysis of tachykinin roles in inflammation, vascular tone, and blood pressure regulation.

Related Experiment Videos

Main Results:

  • Tachykinins, particularly via neurokinin-1 receptors, induce plasma extravasation and neurogenic inflammation.
  • Tachykinins modulate vascular tone, causing relaxation or constriction depending on the context and endothelial state.
  • Tachykinins influence blood pressure and heart rate through central and peripheral actions.

Conclusions:

  • Tachykinins play complex roles in cardiovascular regulation and inflammation.
  • Neurokinin receptors represent potential therapeutic targets for conditions like hypertension, edema, and inflammatory diseases.
  • Further research and disease modeling are needed to realize the therapeutic potential of neurokinin receptor antagonists.